wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34180815-8866B2CB-0479-4B27-B20D-184025CD6CEE
Q34180815-8866B2CB-0479-4B27-B20D-184025CD6CEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-8866B2CB-0479-4B27-B20D-184025CD6CEE
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
P921
Q34180815-8866B2CB-0479-4B27-B20D-184025CD6CEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-8866B2CB-0479-4B27-B20D-184025CD6CEE
rank
NormalRank
type
BestRank
Statement
P921
phase II clinical trial